Argenta Limited, a New Zealand animal health company, has worked with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company, to gain US Federal Drug Administration (FDA) approval of an innovative treatment for river blindness.
28 June 2018
A new diagnostic test using a few drops of blood could be used detect Alzheimer’s disease years before symptoms begin to show. By 2050 more than 170,000 New Zealanders are forecast to have dementia – the majority of which will be Alzheimer’s.
01 February 2018
A pericardium looks more like a cheese slice than high-value biomaterial suitable for repairing human hearts.
24 January 2018
Some medicinal cannabis users say they can see hope but no material changes for them in the government’s proposed legislation.
21 December 2017
Living Cell Technologies Limited has filed a provisional patent for pericyte protective agents titled “PERICYTE PROTECTIVE AGENTS FOR NEUROLOGICAL DISORDERS INCLUDING NEURODEGENERATIVE DISEASES, CENTRAL NERVOUS SYSTEM DISEASES AND OTHERS”.
08 November 2017
Follow the link to listen to Andrew Pattersons interview with Dr Clyde Smith starts at 22:30
23 October 2017
A handheld gadget used to scan for diseases in the sci-fi series Star Trek could soon become reality, with a new Kiwi study targeting our high rates of skin cancer.
26 September 2017
Current healthcare trends would be witnessing more changes (or disruptions) as the impact of the Fourth Industrial Revolution (4IR) takes effect worldwide.
13 September 2017
13 September 2017
Precision Driven Health (PDH) is a seven-year NZ$38m research partnership aimed at improving health outcomes through data science. The partnership centres around the international movement towards precision medicine, the growing body of international research that is identifying and enabling the capture and analysis of the big data that will facilitate healthcare to be tailored to … Continue reading "Precision Driven Health Finalist in NZ Innovation Awards"